Close
Nordic 9Nordic 9

SR One (investor - Corporate Investor)

United States srone.com
See something wrong or missing? Let us know
Offices:Cambridge

SR One is the corporate venture capital arm of GlaxoSmithKline.

Average round investment:67.64M USD
Average number per year:1.8
Distribution: 2025 (3)2024 (3)2022 (1)2021 (1)2020 (1)
Portfolio companies: United Kingdom Mission TherapeuticsUnited Kingdom Charm TherapeuticsUnited Kingdom Draig Therapeutics See the entire list
Mostly invests in: United Kingdom United Kingdom (7) Health services (9)
See the entire list

Showing 3 of 9 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

SR One mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to SR One

Name Criteria
United Kingdom Hermes GPE
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Software Services, AI (big data), Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Sweden SEB Bank
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Software Services, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Polaris Partners
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Software Services, AI (big data), Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Denmark, Switzerland
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Germany BMW i Ventures
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Software Services, AI (big data), Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom, Switzerland
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
United Kingdom Unbound Advisors
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Software Services, Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
Netherlands Snowflake Software
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Software Services, AI (big data), Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Germany Burda Principal Investments
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Software Services, AI (big data), Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom, Denmark
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
Hong Kong Horizons Ventures
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Software Services, AI (big data), Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom, Switzerland
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
Germany DTCP
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Software Services, AI (big data), Manufacturing
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.2
  • Active last 12 months: Yes
Denmark The Aventures
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Denmark
  • Average number of deals per year: 3.3
  • Active last 12 months: Yes
Top